Nuwellis Financials - Benzinga

Nuwellis Inc

NUWENASDAQ

Trade with Public

Trade with Public

$0.7925

-0.0964-10.84%

At close: Aug 28, 5:00 PM EST

$0.7790

-0.11-12.36%

Pre-Market: 4:01 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Nuwellis Financials

Nuwellis (NUWE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Nuwellis Q2 EPS $(26.64) Misses $(0.68) Estimate, Sales $1.969M Miss $2.415M Estimate

Benzinga Newsdesk

Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending

Nuwellis shares surged 89.97% after hours following recent pediatric hospital expansion and strong preliminary second-quarter revenue growth.

Mohd Haider

PRO
Nuwellis Announces Preliminary Q2 Earnings With YoY Q2 Revenue Growth Of 14% And H2 Revenue Growth Of 20%

Management expects to report its financial results for the three and six months ended June 30, 2026, before the open of the U.S. financial markets on August 13th and will host a conference call and webcast beginning at

Benzinga Newsdesk

PRO
Nuwellis Q1 EPS $(2.09) Misses $(1.00) Estimate, Sales $2.403M Beat $2.094M Estimate

Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(2.09) per share which missed the analyst consensus estimate of $(1.00) by 109 percent. This is a 92.79 percent increase over losses of $(28.98) per share from the

Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

PRO
Nuwellis Q4 EPS $(1.50) Beats $(1.56) Estimate, Sales $2.424M Beat $2.310M Estimate

Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.56) by 3.85 percent. This is a 91.8 percent increase over losses of $(18.30) per share from the same

Benzinga Newsdesk